ES2140575T3 - L-lisil-glicil-l-histidina y agente terapeutico para curar heridas que lo contiene. - Google Patents

L-lisil-glicil-l-histidina y agente terapeutico para curar heridas que lo contiene.

Info

Publication number
ES2140575T3
ES2140575T3 ES95107298T ES95107298T ES2140575T3 ES 2140575 T3 ES2140575 T3 ES 2140575T3 ES 95107298 T ES95107298 T ES 95107298T ES 95107298 T ES95107298 T ES 95107298T ES 2140575 T3 ES2140575 T3 ES 2140575T3
Authority
ES
Spain
Prior art keywords
glicil
lisil
histidine
therapeutic agent
heal wounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95107298T
Other languages
English (en)
Inventor
Masayoshi Koyama
Mikiko Takahashi
Masayoshi Yanagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis KK
Original Assignee
Hoechst Japan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan Ltd filed Critical Hoechst Japan Ltd
Application granted granted Critical
Publication of ES2140575T3 publication Critical patent/ES2140575T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L-LISIL-GLICIL-L-HISTIDINA Y COMPLEJOS METALICOS DE LA MISMA, POR EJEMPLO, L-LISIL-GLICIL-L-HISTIDINA: COBRE (II). LA L-LISIL-GLICIL-L-HISTIDINA Y SAL DE LA MISMA TIENEN UNA ACTIVIDAD PROMOTORA DE LA PROLIFERACION DE FIBROBLASTO, SIENDO DE ESE MODO UTIL COMO AGENTE PARA CURAR HERIDAS.
ES95107298T 1994-05-27 1995-05-13 L-lisil-glicil-l-histidina y agente terapeutico para curar heridas que lo contiene. Expired - Lifetime ES2140575T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6115161A JPH07316192A (ja) 1994-05-27 1994-05-27 Ｌ−リシル−グリシル−ｌ−ヒスチジンおよびこれを含有する創傷治療剤

Publications (1)

Publication Number Publication Date
ES2140575T3 true ES2140575T3 (es) 2000-03-01

Family

ID=14655848

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95107298T Expired - Lifetime ES2140575T3 (es) 1994-05-27 1995-05-13 L-lisil-glicil-l-histidina y agente terapeutico para curar heridas que lo contiene.

Country Status (11)

Country Link
US (1) US5591711A (es)
EP (1) EP0684259B1 (es)
JP (1) JPH07316192A (es)
KR (1) KR950032272A (es)
AT (1) ATE186734T1 (es)
AU (1) AU705569B2 (es)
CA (1) CA2150334A1 (es)
DE (1) DE69513324T2 (es)
DK (1) DK0684259T3 (es)
ES (1) ES2140575T3 (es)
GR (1) GR3032077T3 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
GB2321191B (en) * 1997-01-17 2000-09-27 Johnson & Johnson Medical Peptides for use in wound treatment
AU6959898A (en) 1997-04-11 1998-11-11 David J. Grainger Compounds and therapies for the prevention of vascular and non-vascular pathol ogies
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20030158111A1 (en) * 1999-10-01 2003-08-21 David Bar-Or Methods and products for oral care
KR20020057966A (ko) 1999-10-01 2002-07-12 디엠아이 바이오사이언시스, 인크 금속 결합 화합물 및 그의 용도
US7592304B2 (en) * 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20030130185A1 (en) * 2000-09-29 2003-07-10 David Bar-Or Metal-binding compounds and uses therefor
EP4157820A4 (en) * 2020-06-01 2024-07-03 Balchem Corp METAL DI-AMINO ACID CHELATES OR METAL TRI-AMINO ACID CHELATES

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760051A (en) * 1985-01-24 1988-07-26 Pickart Loren R Use of GHL-Cu as a wound-healing and anti-inflammatory agent
US5120831A (en) * 1985-02-08 1992-06-09 Procyte Corporation Metal-peptide compositions
US4810693A (en) * 1985-02-08 1989-03-07 Procyte Corporation Method for inducing biological coverings in wounds
US5023237A (en) * 1989-08-30 1991-06-11 Procyte Corporation Methods and compositions for healing ulcers
US5059588A (en) * 1989-10-13 1991-10-22 Procyte Corporation, Incorporated Methods and compositions for healing bone using gly his lys: copper
US5386012A (en) * 1990-02-06 1995-01-31 Strid; Lars Growth factor in connection with artificial implants
US5118665A (en) * 1990-02-09 1992-06-02 Procyte Corporation Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof
US5164367A (en) * 1990-03-26 1992-11-17 Procyte Corporation Method of using copper(ii) containing compounds to accelerate wound healing

Also Published As

Publication number Publication date
CA2150334A1 (en) 1995-11-28
DK0684259T3 (da) 2000-05-08
US5591711A (en) 1997-01-07
EP0684259B1 (en) 1999-11-17
AU705569B2 (en) 1999-05-27
DE69513324D1 (de) 1999-12-23
EP0684259A1 (en) 1995-11-29
AU2028995A (en) 1995-12-07
KR950032272A (ko) 1995-12-20
DE69513324T2 (de) 2000-04-13
ATE186734T1 (de) 1999-12-15
JPH07316192A (ja) 1995-12-05
GR3032077T3 (en) 2000-03-31

Similar Documents

Publication Publication Date Title
MY119711A (en) Method of inhibiting photoaging of skin
ES2194308T3 (es) Utilizacion de sustancias con una actividad de oxitocina en la preparacion de medicamentos para la curacion de heridas.
BR9906477A (pt) Cicatrizante de feridas enriquecido com plaquetas aperfeiçoado
ES2140575T3 (es) L-lisil-glicil-l-histidina y agente terapeutico para curar heridas que lo contiene.
PT1052905E (pt) Processo anti-germinativo de tuberculos e bolbos utilizando o eugenol e/ou o isoeugenol
WO2002085288A3 (en) Stable antimicrobials in structured water
EA200300849A1 (ru) Способы лечения или профилактики кожных заболеваний с помощью cd2-связывающих агентов
IL138290A0 (en) Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
DE69705110D1 (de) Topische pharmazeutische zusammensetzungen, welche heparin enthalten
GB0127822D0 (en) Medical dressings
BG101126A (en) The use of muramylpeptide compounds
BR0109896A (pt) Composição tópica em gel, curativo de feridas, seu método e uso
GR3031890T3 (en) Use of topically applied factor xiii for inhibiting hemorrhage.
AU559768B2 (en) Aluminium or zinc panthenolate and their use for treating wounds
EA199800928A1 (ru) Соединения из класса ацилмочевин, предназначенные для лечения кокцидиоидомикоза у теплокровных животных
HK1048263A1 (en) Medicaments that contain xenogenic oligo-or/and polyribonucleotides.
DE69626691D1 (de) Komponente b als wundheilendes mittel
GB9723824D0 (en) Cytostatic agents
RU96106405A (ru) Способ создания средства для лечения ран
UA33359A (uk) Спосіб доступу до пухлин орбіти
BR0207681A (pt) Combinações sinérgicas de ligantes do receptor retinóide e agentes citotóxicos selecionados para tratamento do câncer
UA8280A (uk) Спосіб лікування псоріазу
UA32281A (uk) Засіб "регенерин" для зовнішнього лікування гнійних ран і трофічних виразок
UA31289A (uk) Спосіб лікування запальних захворювань щелепо-лицевої ділянки

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 684259

Country of ref document: ES